Literature DB >> 24920728

Toll-like receptors and hypertension.

Madhu V Singh1, François M Abboud2.   

Abstract

Hypertension and associated inflammatory processes that accelerate cardiovascular damage are regulated by the innate immune system. Toll-like receptors (TLR) are major components of the innate immune system that recognize endogenous damage-associated molecular patterns to activate prominent inflammatory signaling including activation of nuclear factor-κB (NF-κB). However, the role of TLR in the etiology of hypertension is not well understood. TLR signaling is dependent on adaptor proteins that, along with the TLR expression patterns, confer specificity of the inflammatory response and its pathological targets. Here we review the conceptual framework of how TLR and their adaptor proteins may differentially affect hypertension and cardiac hypertrophy by different stimuli.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  MyD88; hypertension; innate immune system; toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 24920728      PMCID: PMC4214832          DOI: 10.1152/ajpregu.00194.2014

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  34 in total

1.  Does interleukin 6 contribute to renal hemodynamic changes during angiotensin II-dependent hypertension?

Authors:  Michael J Ryan
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

Review 2.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 3.  The structural biology of Toll-like receptors.

Authors:  Istvan Botos; David M Segal; David R Davies
Journal:  Structure       Date:  2011-04-13       Impact factor: 5.006

4.  Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats.

Authors:  Bernardo Rodríguez-Iturbe; Atilio Ferrebuz; Valentina Vanegas; Yasmir Quiroz; Sergio Mezzano; Nosratola D Vaziri
Journal:  J Pharmacol Exp Ther       Date:  2005-06-10       Impact factor: 4.030

5.  Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes.

Authors:  T Kawai; O Takeuchi; T Fujita; J Inoue; P F Mühlradt; S Sato; K Hoshino; S Akira
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

6.  Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension.

Authors:  Dong-Jie Li; Roger G Evans; Zhong-Wei Yang; Shu-Wei Song; Pei Wang; Xiu-Juan Ma; Chong Liu; Tao Xi; Ding-Feng Su; Fu-Ming Shen
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

Review 7.  Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension.

Authors:  Jasenka Zubcevic; Hidefumi Waki; Mohan K Raizada; Julian F R Paton
Journal:  Hypertension       Date:  2011-05-02       Impact factor: 10.190

Review 8.  Inflammation, immunity, and hypertension.

Authors:  David G Harrison; Tomasz J Guzik; Heinrich E Lob; Meena S Madhur; Paul J Marvar; Salim R Thabet; Antony Vinh; Cornelia M Weyand
Journal:  Hypertension       Date:  2010-12-13       Impact factor: 10.190

9.  Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats.

Authors:  Bernardo Rodríguez-Iturbe; Yasmir Quiroz; Atilio Ferrebuz; Gustavo Parra; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2004-11-23       Impact factor: 3.754

10.  Hypertension augments cardiac Toll-like receptor 4 expression and activity.

Authors:  Ruth Eissler; Christoph Schmaderer; Krisztina Rusai; Louisa Kühne; Daniel Sollinger; Tobias Lahmer; Oliver Witzke; Jens Lutz; Uwe Heemann; Marcus Baumann
Journal:  Hypertens Res       Date:  2011-01-20       Impact factor: 3.872

View more
  18 in total

Review 1.  Immune Mechanisms in Arterial Hypertension.

Authors:  Ulrich Wenzel; Jan Eric Turner; Christian Krebs; Christian Kurts; David G Harrison; Heimo Ehmke
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  Toll-Like Receptors, Hypertension, and an Antimalarial Drug.

Authors:  Madhu V Singh
Journal:  Am J Hypertens       Date:  2016-10-04       Impact factor: 2.689

Review 3.  Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota.

Authors:  David J Durgan
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

4.  Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.

Authors:  Jing Chen; Joshua D Bundy; L Lee Hamm; Chi-Yuan Hsu; James Lash; Edgar R Miller; George Thomas; Debbie L Cohen; Matthew R Weir; Dominic S Raj; Hsiang-Yu Chen; Dawei Xie; Panduranga Rao; Jackson T Wright; Mahboob Rahman; Jiang He
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 5.  Toll-like Receptors in the Vascular System: Sensing the Dangers Within.

Authors:  Styliani Goulopoulou; Cameron G McCarthy; R Clinton Webb
Journal:  Pharmacol Rev       Date:  2016-01       Impact factor: 25.468

6.  Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.

Authors:  Madhu V Singh; Michael Z Cicha; Sarah Nunez; David K Meyerholz; Mark W Chapleau; François M Abboud
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-22       Impact factor: 4.733

7.  S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.

Authors:  Ana Paula Cremasco Takano; Carolina Demarchi Munhoz; Anselmo Sigari Moriscot; Sudhiranjan Gupta; Maria Luiza Morais Barreto-Chaves
Journal:  J Mol Med (Berl)       Date:  2017-02-04       Impact factor: 4.599

8.  Antagonism of major histocompatibility complex class II invariant chain peptide during chronic lipopolysaccharide treatment rescues autoregulatory behavior.

Authors:  Justin P Van Beusecum; Shali Zhang; Estevan Beltran; Anthony K Cook; Richard P Tobin; M Karen Newell-Rogers; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-21

9.  Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Babak Baban; Jennifer C Sullivan; Takayuki Matsumoto; R Clinton Webb
Journal:  Cardiovasc Res       Date:  2015-04-24       Impact factor: 10.787

Review 10.  T-cell involvement in sex differences in blood pressure control.

Authors:  G Ryan Crislip; Jennifer C Sullivan
Journal:  Clin Sci (Lond)       Date:  2016-05-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.